XML 80 R63.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Infusion Pump and Business Optimization Charges - Additional Information (Detail) - USD ($) | 12 Months Ended
--- | ---
Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | Dec. 31, 2014
Infusion Pump and Business Optimization Charges [Line Items] |  |  |  |
Cumulative pre-tax costs incurred | $ 576,000,000 |  |  |
Expected additional pre-tax cash costs | 240,000,000 |  |  |
Expected capital expenditures | $ 50,000,000 |  |  |
Additional business optimization charges, net |  | $ 125,000,000 |  |
Business optimization charges non-cash percentage | 40.00% |  |  |
Business optimization anticipated additional costs to be incurred | $ 0 |  |  |
Restructuring charges | 70,000,000 | 285,000,000 | $ 130,000,000 |
Costs to implement business optimization programs | 89,000,000 | 65,000,000 |  |
Accelerated depreciation | $ 10,000,000 | 33,000,000 |  |
Percentage of restructuring reserves related to employee termination costs | 90.00% |  |  |
VIVIA Home Hemodialysis Development Program |  |  |  |
Infusion Pump and Business Optimization Charges [Line Items] |  |  |  |
Restructuring charges |  | 54,000,000 |  |
Employee Termination Costs |  |  |  |
Infusion Pump and Business Optimization Charges [Line Items] |  |  |  |
Restructuring charges | $ 78,000,000 | 194,000,000 | 115,000,000 |
Employee Termination Costs | Global Workforce Reduction Program |  |  |  |
Infusion Pump and Business Optimization Charges [Line Items] |  |  |  |
Restructuring charges | 59,000,000 | 180,000,000 | 83,000,000 |
Asset Impairment Related to Facility Closure Costs |  |  |  |
Infusion Pump and Business Optimization Charges [Line Items] |  |  |  |
Restructuring charges | 6,000,000 |  |  |
Other exit costs |  |  |  |
Infusion Pump and Business Optimization Charges [Line Items] |  |  |  |
Restructuring charges | 5,000,000 |  |  |
Other exit costs | VIVIA Home Hemodialysis Development Program |  |  |  |
Infusion Pump and Business Optimization Charges [Line Items] |  |  |  |
Restructuring charges |  | 2,000,000 |  |
Asset Impairment |  |  |  |
Infusion Pump and Business Optimization Charges [Line Items] |  |  |  |
Restructuring charges | 6,000,000 | 78,000,000 | 42,000,000 |
Asset Impairment | In-process research and development (IPR&D) | Renal |  |  |  |
Infusion Pump and Business Optimization Charges [Line Items] |  |  |  |
Restructuring charges |  | 27,000,000 |  |
Asset Impairment | Developed Technology |  |  |  |
Infusion Pump and Business Optimization Charges [Line Items] |  |  |  |
Restructuring charges |  |  | 13,000,000 |
Asset Impairment | VIVIA Home Hemodialysis Development Program |  |  |  |
Infusion Pump and Business Optimization Charges [Line Items] |  |  |  |
Restructuring charges |  | 31,000,000 |  |
Asset Impairment | Manufacturing Facility Rationalization Program |  |  |  |
Infusion Pump and Business Optimization Charges [Line Items] |  |  |  |
Restructuring charges |  |  | 29,000,000 |
Contract termination costs |  |  |  |
Infusion Pump and Business Optimization Charges [Line Items] |  |  |  |
Restructuring charges | 5,000,000 | 27,000,000 | 5,000,000 |
Contract termination costs | VIVIA Home Hemodialysis Development Program |  |  |  |
Infusion Pump and Business Optimization Charges [Line Items] |  |  |  |
Restructuring charges |  | 21,000,000 |  |
Severance and Other Employee Related Costs |  |  |  |
Infusion Pump and Business Optimization Charges [Line Items] |  |  |  |
Restructuring charges | 83,000,000 | 221,000,000 | 120,000,000 |
Restructuring reserves | 112,000,000 | 164,000,000 | 116,000,000 | $ 127,000,000
Severance and Other Employee Related Costs | Accounts Payable and Accrued Liabilities |  |  |  |
Infusion Pump and Business Optimization Charges [Line Items] |  |  |  |
Restructuring reserves | 100,000,000 |  |  |
Severance and Other Employee Related Costs | Other Long-term Liabilities |  |  |  |
Infusion Pump and Business Optimization Charges [Line Items] |  |  |  |
Restructuring reserves | 12,000,000 |  |  |
SIGMA Spectrum Infusion Pump |  |  |  |
Infusion Pump and Business Optimization Charges [Line Items] |  |  |  |
Infusion pump and other product-related charges | 22,000,000 |  |  | 93,000,000
Cash reserves utilized | $ 2,000,000 | 22,000,000 | 13,000,000 | $ 4,000,000
Infusion pump charges related to cash |  | 11,000,000 | 26,000,000 |
Infusion pump charges related asset impairments |  | 1,000,000 | $ 10,000,000 |
Non-cash reserves utilized |  | $ 3,000,000 |  |

X
- Definition Additional business optimization charges net. + References No definition available. + Details
Name: | bax_AdditionalBusinessOptimizationChargesNet
Namespace Prefix: | bax_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Business optimization anticipated additional costs to be incurred. + References No definition available. + Details
Name: | bax_BusinessOptimizationAnticipatedAdditionalCostsToBeIncurred
Namespace Prefix: | bax_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Business optimization charges non-cash percentage. + References No definition available. + Details
Name: | bax_BusinessOptimizationChargesNonCashPercentage
Namespace Prefix: | bax_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Costs to implement business optimization programs. + References No definition available. + Details
Name: | bax_CostsToImplementBusinessOptimizationPrograms
Namespace Prefix: | bax_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Infusion pump and business optimization charges. + References No definition available. + Details
Name: | bax_InfusionPumpAndBusinessOptimizationChargesLineItems
Namespace Prefix: | bax_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Infusion pump reserve charge. + References No definition available. + Details
Name: | bax_InfusionPumpReserveCharge
Namespace Prefix: | bax_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Infusion pump reserve utilization. + References No definition available. + Details
Name: | bax_InfusionPumpReserveUtilization
Namespace Prefix: | bax_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Infusion pump reserves cash. + References No definition available. + Details
Name: | bax_InfusionPumpReservesCash
Namespace Prefix: | bax_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Infusion pump reserves non cash. + References No definition available. + Details
Name: | bax_InfusionPumpReservesNonCash
Namespace Prefix: | bax_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Infusion pump reserves non-cash utilization. + References No definition available. + Details
Name: | bax_InfusionPumpReservesNonCashUtilization
Namespace Prefix: | bax_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Percentage of restructuring reserves related to employee termination costs. + References No definition available. + Details
Name: | bax_PercentageOfRestructuringReservesRelatedToEmployeeTerminationCosts
Namespace Prefix: | bax_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Restructuring and related cost expected capital expenditures. + References No definition available. + Details
Name: | bax_RestructuringAndRelatedCostExpectedCapitalExpenditures
Namespace Prefix: | bax_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of costs incurred to date for the specified restructuring cost. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 5.P.4(b)) -URI http://asc.fasb.org/extlink&oid=27011515&loc=d3e140904-122747 + Details
Name: | us-gaap_RestructuringAndRelatedCostCostIncurredToDate1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount expected to be recognized in earnings for the specified restructuring cost. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 5.P.4(b)) -URI http://asc.fasb.org/extlink&oid=27011515&loc=d3e140904-122747 + Details
Name: | us-gaap_RestructuringAndRelatedCostExpectedCost1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 5.P.3) -URI http://asc.fasb.org/extlink&oid=27011515&loc=d3e140864-122747 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3602-108585 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 5.P.4(b)) -URI http://asc.fasb.org/extlink&oid=27011515&loc=d3e140904-122747 + Details
Name: | us-gaap_RestructuringCharges
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SAB TOPIC 5.P.4(b)) -URI http://asc.fasb.org/extlink&oid=27011515&loc=d3e140904-122747 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b)(2) -URI http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869 + Details
Name: | us-gaap_RestructuringReserve
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of accelerated depreciation charged against earnings associated with exit from or disposal of business activities or restructuring plan. + References No definition available. + Details
Name: | us-gaap_RestructuringReserveAcceleratedDepreciation
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | us-gaap_RestructuringPlanAxis=bax_VIVIAHomeHemodialysisDevelopmentProgramMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RestructuringPlanAxis=bax_GlobalWorkforceReductionProgramMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RestructuringCostAndReserveAxis=bax_AssetImpairmentRelatedToFacilityClosingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RestructuringCostAndReserveAxis=bax_AssetImpairmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=bax_RenalMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RestructuringPlanAxis=bax_ManufacturingFacilityRationalizationProgramMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RestructuringCostAndReserveAxis=us-gaap_ContractTerminationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RestructuringCostAndReserveAxis=bax_SeveranceAndOtherEmployeeRelatedCostsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsPayableAndAccruedLiabilitiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ProductOrServiceAxis=bax_SIGMASpectrumInfusionPumpMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |